Amoeba SA

Research Amoeba SA (ALMIB) on Bullrun: market cap EUR 54.70M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALMIB
• ExchangePA
• CountryFrance
• SectorBasic Materials
• IndustryAgricultural Inputs
• CurrencyEUR
• Market capEUR 54.70M
• Financial periodFY2025
• Net income-EUR 8.30M
• Free cash flow-EUR 6.95M

Valuation Snapshot

latest market cap is EUR 54.70M.

About Amoeba SA

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is headquartered in Chassieu, France.

Frequently asked questions

What is Amoeba SA's market cap?

Amoeba SA's market capitalization is EUR 54.70M.

What does Amoeba SA do?

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France.